Evaluating Clinical Safety of BTK Inhibitors: Cardiovascular Events and Drug-Drug InteractionsByKim Nguyen, PharmD,Diego Villa, MD, FRCPC,Xue Feng, PharmD, BCOPJune 19th 2026This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.